Stock of the day: Integral Diagnostics
Integral Diagnostics strengthens its market position by acquiring Capital Health, approved by ASIC. The merger presents significant investment opportunities due to undervaluation.
(AI video summary)
This video was created on 11 December for IG audiences by ausbiz.
ASX code: IDX
Strategic acquisition enhances Integral Diagnostics' market position
Integral Diagnostics has made headlines with its acquisition of Capital Health, following approval from the Australian Securities and Investments Commission (ASIC). This merger, contingent upon the divestment of a Capital clinic in Melton, Victoria, is set to be implemented by 20 December 2024.
The acquisition positions Integral Diagnostics to control 63% of the combined entity, with Capital Health holding the remaining 37%. This strategic move is expected to enhance operational efficiencies across 155 clinics, involving 350 radiologists and 3000 employees, generating approximately $650 million in revenue.
The potential for cost efficiencies and improved margins is significant, given the current 5% efficiency and 94% margins.
Valuation and earnings potential in healthcare sector
Integral Diagnostics is trading at a relatively low price-to-earnings (P/E) ratio compared to its peers in the healthcare sector, such as Sonic Healthcare. With a forecasted earnings per share (EPS) growth of 30%, the merger presents a compelling opportunity for investors.
The healthcare sector typically trades at 30 to 35 times earnings, while Integral Diagnostics is forecasted to trade at around 20 times earnings. This disparity suggests that the company is undervalued, providing a potential upside as cost efficiencies from the merger materialise over the next 12 to 18 months.
Challenges and opportunities in mergers and acquisitions
While the merger offers promising growth, successful integration is crucial. The process of merging two companies involves aligning cultures and realising synergies, which can be challenging. Management disruptions and egos may pose hurdles, but the potential benefits of scale and efficiency gains are significant.
Additionally, advancements in artificial intelligence (AI) are expected to further enhance operational efficiencies, making the merger an intriguing prospect. Both industry experts suggest holding the stock, recognising the potential for long-term growth as the merger's benefits unfold.
The information on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG Bank S.A. accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer.
Explore the markets with our free course
Learn how shares work – and discover the wide range of markets you can trade CDFs on – with IG Academy's free ’introducing the financial markets’ course.
Put learning into action
Try out what you’ve learned in this shares strategy article risk-free in your demo account.
Ready to trade shares?
Put the lessons in this article to use in a live account – upgrading is quick and easy.
- Trade over 12 000 popular global stocks
- Protect your capital with risk management tools
- React to breaking news with out-of-hours trading on 70 key US stocks
Inspired to trade?
Put your new knowledge into practice. Log in to your account now.
Live prices on most popular markets
- Forex
- Shares
- Indices
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.